Home › Gastrointestinal Cancers › New York
Gastrointestinal Cancers clinical trials in New York
14 studies for Gastrointestinal Cancers are looking for participants at sites in New York.
Cities in New York
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
- Montefiore Medical Center-Einstein Campus, The Bronx
- James J Peters VA Medical Center, The Bronx
RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT07283939Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- NYOH Albany Cancer Center, Albany
- Hematology-Oncology Associates of Central New York, PC, Auburn
- North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, Babylon
- and 12 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07222800A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
- GSK Investigational Site, New Hyde Park
- GSK Investigational Site, New York
- GSK Investigational Site, New York
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07218926Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Columbia University, New York
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06128551Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- Northwell Health / RJ Zuckerberg Cancer Center, Lake Success
- Columbia University Medical Center, New York
- Memorial Sloan Kettering Cancer Center Main Campus, New York
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06445062Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients
- Roswell Park Comprehensive Cancer Center, Buffalo
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05274048A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
- Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- and 1 more
Recruiting
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT05837767Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
- New York Cancer & Blood Specialists, New York
- University of Rochester - Wilmot Cancer Institute, Rochester
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 27, 2026 · NCT06582017A Study on the Effects of Exercise on Side Effects From Treatment for Gastrointestinal Cancers
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- and 1 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT05789485A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)
- GSK Investigational Site, New York
- GSK Investigational Site, New York
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 3, 2026 · NCT06885034Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
- NYU Langone, New York
- Memorial Sloan Kettering Cancer Center, New York
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jun 3, 2026 · NCT06040541Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- Perlmutter Cancer Center at NYU Langone Health, New York
- Memorial Sloan-Kettering Cancer Center, New York
- Columbia University, New York
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated May 15, 2026 · NCT05379985A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
- Laura & Isaac Perlmutter Cancer Center at NYU Langone, New York
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Apr 22, 2026 · NCT07020221Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors
- The New York Proton Center, New York
Recruiting
Ages 18 and older · All sexes · Updated Apr 13, 2026 · NCT05313191From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.